Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117884022 | 11788402 | 2 | F | 20160829 | 20151201 | 20160906 | EXP | US-ROCHE-1670041 | ROCHE | , STASHI E, PAL N, URBAUER D, JANKU F, PIHA-PAUL S, NAING A, TSIMBERIDOU A, FU S, HONG D, SUBBIAH V, KARP D, COLEMAN R, MERIC-BERNSTAM F, KURZROCK R. PHASE I TRIAL OF PACLITAXEL, BEVACIZUMAB, AND TEMSIROLIMUS IN ADVANCED SOLID MALIGNANCIES. JOURNAL OF CLINICAL ONCOLOGY 2016 MAY;34 (15SUP):-. | 0.00 | Y | 0.00000 | 20160906 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117884022 | 11788402 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | Q3W | |||||||||
| 117884022 | 11788402 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | U | 0 | Q3W | |||||||||
| 117884022 | 11788402 | 3 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 117884022 | 11788402 | 4 | SS | SORAFENIB | SORAFENIB | 1 | Unknown | ONCE OR TWICE DAILY | U | 0 | |||||||||
| 117884022 | 11788402 | 5 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117884022 | 11788402 | 1 | Neoplasm |
| 117884022 | 11788402 | 2 | Neoplasm |
| 117884022 | 11788402 | 3 | Neoplasm |
| 117884022 | 11788402 | 4 | Neoplasm |
| 117884022 | 11788402 | 5 | Neoplasm |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117884022 | 11788402 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117884022 | 11788402 | Anaemia | |
| 117884022 | 11788402 | Diarrhoea | |
| 117884022 | 11788402 | Fatigue | |
| 117884022 | 11788402 | Headache | |
| 117884022 | 11788402 | Hypertriglyceridaemia | |
| 117884022 | 11788402 | Mucosal inflammation | |
| 117884022 | 11788402 | Nausea | |
| 117884022 | 11788402 | Neutropenia | |
| 117884022 | 11788402 | Pain | |
| 117884022 | 11788402 | Thrombocytopenia | |
| 117884022 | 11788402 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |